#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari

Verifiedinfo

Italy Piazzale Giulio Cesare 11, 70124 Bari, Italy

20 trials recruiting
Plasma cell myeloma · Type 2 diabetes mellitus · IgA nephropathy
Adults and children

About Specializations

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari in Bari, Italy specialises in clinical trials of conditions such as Plasma cell myeloma, Type 2 diabetes mellitus, IgA nephropathy, Partial seizures, and other specialisations. This site conducts important research.

Main research areas of the site

Hematology and Oncology

The medical center is at the forefront of hematology and oncology research, focusing on innovative treatments for blood cancers. The center's commitment to advancing therapeutic options is evident through its involvement in cutting-edge clinical trials.

Acute Myeloid Leukemia (AML)
FLT3-ITD Negative AML
Targeted Therapy Development

By exploring novel agents like quizartinib, the center aims to improve survival outcomes and quality of life for patients with challenging hematologic malignancies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Piazzale Giulio Cesare 1170124 BariItaly

Open in maps ↗

Recruiting now: 20 trials
Conditions studied: 48
Partner status: Verified

More sites in Bari Italy

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

55 clinical trials

Crohn's disease

Recruiting

Investigational

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Ro7790121
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Recruiting

Registered drug

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Bacteraemia

Recruiting

Registered drugNo placebo

Comparing piperacillin-tazobactam and meropenem for treating bloodstream infections caused by cephalosporin-resistant bacteria in adult patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Meropenem Anhydrous
Sponsor:Azienda Ospedaliero Universitaria Di Modena

Contact Research Centre

B-cell small lymphocytic lymphoma refractory+1

Recruiting

Registered drugNo placebo

Study of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Obinutuzumab
Sponsor:BeOne Medicines AG

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Investigational

Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Dnth103
Sponsor:Dianthus Therapeutics Inc.

Contact Research Centre

Study on the Effectiveness and Safety of Colesevelam Hydrochloride for Patients with Idiopathic Bile Acid Diarrhea (BAD)

Recruiting

Investigational

Study on the Effectiveness and Safety of Colesevelam Hydrochloride for Patients with Idiopathic Bile Acid Diarrhea (BAD)

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:COLESEVELAM HYDROCHLORIDE
Sponsor:Cosmo Technologies Limited

Contact Research Centre

Metastatic renal cell carcinoma

Recruiting

Registered drugNo placebo

Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Axitinib
Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Contact Research Centre

Myopia

Recruiting

Investigational

Study of atropine eye drops (0.

Investigational

Italy

Participants:0–17 years
Substances:Atropine Sulfate Monohydrate
Sponsor:Ocus Innovation Ireland Limited

Contact Research Centre

Hairy cell leukaemia

Recruiting

Registered drugNo placebo

Study of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cladribine
Sponsor:Universita Degli Studi Di Perugia

Contact Research Centre

Radiologically isolated syndrome

Recruiting

Registered drug

Study of BCG Vaccine and Sodium Chloride for Patients with Radiologically Isolated Syndrome (RIS)

Registered drug

Italy

Participants:18–64 years
Substances:Sodium Chloride
Sponsor:Fondazione Italiana Sclerosi Multipla Ente Del Terzo Settore/et S

Contact Research Centre

IgA nephropathy

Recruiting

Investigational

Study on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:ZIGAKIBART
Sponsor:Novartis Pharma AG

Contact Research Centre

Medulloblastoma

Recruiting

Registered drugNo placebo

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years
Substances:Carboplatin
Sponsor:University Medical Center Hamburg-Eppendorf

Contact Research Centre

Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.